[{"orgOrder":0,"company":"MenoLabs","sponsor":"Dr. Reddy's Laboratories","pharmaFlowCategory":"D","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Other Large Molecule","year":"2024","type":"Acquisition","leadProduct":"Bifidobacterium Animalis","moa":"||Undisclosed","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Approved FDF","graph3":"MenoLabs","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"MenoLabs \/ Dr. Reddy's Laboratories","highestDevelopmentStatusID":"15","companyTruncated":"MenoLabs \/ Dr. Reddy's Laboratories"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"||Dopamine receptor","graph1":"Neurology","graph2":"Approved FDF","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Bened Biomedical \/ Inapplicable","highestDevelopmentStatusID":"15","companyTruncated":"Bened Biomedical \/ Inapplicable"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"||Dopamine receptor","graph1":"Neurology","graph2":"Approved FDF","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Bened Biomedical \/ Inapplicable","highestDevelopmentStatusID":"15","companyTruncated":"Bened Biomedical \/ Inapplicable"},{"orgOrder":0,"company":"AB Biotics","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"||Dopamine receptor","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"AB Biotics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Oral","sponsorNew":"AB Biotics \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"AB Biotics \/ Inapplicable"},{"orgOrder":0,"company":"Green Cross Wellbeing","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"||Dopamine receptor","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Undisclosed","graph3":"Green Cross Wellbeing","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Green Cross Wellbeing \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Green Cross Wellbeing \/ Inapplicable"},{"orgOrder":0,"company":"3 Waves Wellness","sponsor":"Kaneka Americas Holding Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"||Dopamine receptor","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"3 Waves Wellness","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"3 Waves Wellness \/ Kaneka Americas Holding Inc.","highestDevelopmentStatusID":"1","companyTruncated":"3 Waves Wellness \/ Kaneka Americas Holding Inc."}]

Find Clinical Drug Pipeline Developments & Deals for Lactobacillus Plantarum

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          3 Waves Wellness

                          Country arrow
                          EPSC
                          Not Confirmed

                          3 Waves Wellness

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          February 05, 2025

                          Lead Product(s) : Lactobacillus Plantarum,Inapplicable

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : Kaneka Americas Holding Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Through the acquisition, Dr. Reddy expand its women’s health and dietary supplement branded portfolio, including MenoFit and MenoGlow probiotics to address the symptoms of menopause.

                          Product Name : MenoFit

                          Product Type : Other Large Molecule

                          Upfront Cash : Undisclosed

                          March 01, 2024

                          Lead Product(s) : Bifidobacterium Animalis,Lactobacillus Gasseri,Lactobacillus Plantarum

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Approved FDF

                          Sponsor : Dr. Reddy\'s Laboratories

                          Deal Size : Undisclosed

                          Deal Type : Acquisition

                          blank

                          03

                          Green Cross Wellbeing

                          Country arrow
                          EPSC
                          Not Confirmed

                          Green Cross Wellbeing

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          September 19, 2022

                          Lead Product(s) : Lactobacillus Plantarum,Inapplicable

                          Therapeutic Area : Pulmonary/Respiratory Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Lactobacillus plantarum PS128 probiotic is natural, safe way to boost mental and neural health, works from within gut to balance levels of dopamine, serotonin, and other molecules.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          June 04, 2022

                          Lead Product(s) : Lactobacillus Plantarum,Inapplicable

                          Therapeutic Area : Neurology

                          Highest Development Status : Approved FDF

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study for its PS128 psychobiotic in treating symptoms of Parkinson's disease (PD). The study was led by a neurologist, Dr. Chin-Song Lu, a renowned researcher fo...

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          February 18, 2021

                          Lead Product(s) : Lactobacillus Plantarum,Inapplicable

                          Therapeutic Area : Neurology

                          Highest Development Status : Preclinical

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          AB Biotics

                          Country arrow
                          EPSC
                          Not Confirmed

                          AB Biotics

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          July 08, 2020

                          Lead Product(s) : Lactobacillus Plantarum,Inapplicable

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Next Gen Pharma

                          Country arrow
                          EPSC
                          Not Confirmed

                          Next Gen Pharma

                          Country arrow
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Paracasei,Lactobacillus Plantarum,Lactobacillus Acidophilus,Lactobacillus Delbrueckii Subsp Bulgaricus,Bifidobacteria Longum,Bifidobacteria Infantis,Bifidobacteria Breve

                          Therapeutic Area : Gastroenterology

                          Study Phase : Phase III

                          Sponsor : Department of Gastroenterology, Govt. Medical College, Kozhikode, Kerala, India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          September 10, 2015

                          Lead Product(s) : Lactobacillus Paracasei,Lactobacillus Plantarum,Lactobacillus Acidophilus,Lactobacillus Delbrueckii Subsp Bulgaricus,Bifidobacteria Longum,Bifidobacteria Infantis,Bifidobacteria Breve

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Phase III

                          Sponsor : Department of Gastroenterology, Govt. Medical College, Kozhikode, Kerala, India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          Nottingham University Hospitals NHS Trust

                          Country arrow
                          EPSC
                          Not Confirmed

                          Nottingham University Hospitals NHS Trust

                          Country arrow
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Paracasei,Lactobacillus Plantarum,Lactobacillus Acidophilus,Lactobacillus Delbrueckii Subsp Bulgaricus,Bifidobacteria Longum,Bifidobacteria Infantis,Bifidobacteria Breve

                          Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)

                          Study Phase : Phase II

                          Sponsor : VSL Pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          October 05, 2012

                          Lead Product(s) : Lactobacillus Paracasei,Lactobacillus Plantarum,Lactobacillus Acidophilus,Lactobacillus Delbrueckii Subsp Bulgaricus,Bifidobacteria Longum,Bifidobacteria Infantis,Bifidobacteria Breve

                          Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)

                          Highest Development Status : Phase II

                          Sponsor : VSL Pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          CD Pharma India

                          Country arrow
                          EPSC
                          Not Confirmed

                          CD Pharma India

                          Country arrow
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Paracasei,Lactobacillus Plantarum,Lactobacillus Acidophilus,Lactobacillus Delbrueckii Subsp Bulgaricus,Bifidobacteria Longum,Bifidobacteria Infantis,Bifidobacteria Breve

                          Therapeutic Area : Neurology

                          Study Phase : Phase II/ Phase III

                          Sponsor : Post Graduate Institute of Medical Education and Research, Chandigarh

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          April 26, 2010

                          Lead Product(s) : Lactobacillus Paracasei,Lactobacillus Plantarum,Lactobacillus Acidophilus,Lactobacillus Delbrueckii Subsp Bulgaricus,Bifidobacteria Longum,Bifidobacteria Infantis,Bifidobacteria Breve

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Post Graduate Institute of Medical Education and Research, Chandigarh

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank